Antiphospholipid antibodies in paediatrics

Eur J Pediatr. 1994 Jul;153(7):472-9. doi: 10.1007/BF01956999.

Abstract

Antiphospholipid antibodies, i.e. circulating auto-antibodies to negatively charged phospholipids, are mainly observed in patients with systemic lupus erythematosus, but may also occur in individuals who lack evidence of a well-defined systemic disease. Several studies have suggested that they may play a direct role in the pathogenesis of recurrent vascular thrombosis, repeated abortions, and thrombocytopenia (so-called antiphospholipid antibody syndrome), although the mechanism by which this occurs is still poorly understood. The management of patients with antiphospholipid antibody-related thrombosis includes anti-aggregants, anticoagulants, corticosteroids, and cytotoxic drugs, but the optimum treatment is still controversial. Here we review the test systems used to detect antiphospholipid antibodies and their significance in paediatrics.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Antibodies, Antiphospholipid / immunology*
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Infant
  • Lupus Erythematosus, Systemic / immunology*
  • Male
  • Thrombosis / drug therapy
  • Thrombosis / immunology

Substances

  • Antibodies, Antiphospholipid